Invest Now

Beyond Profits: Where Your Investment Saves Lives

In a world gripped by the ravages of substance use disorders, Ethema Health Corporation emerges as a beacon of hope, passionately dedicated to broadening its reach and impact to bring wellness to more communities and individuals.

When you invest in Ethema, you join a mission that not only fosters financial growth, but one that also fosters profound recovery and resilience.

THE OPPORTUNITY

A message from our CEO

Invest in Ethema =
A Growth Approach That Heals

1

Growth

Ethema Health offers an opportunity to unlock unprecedented expansion in a sector ripe for transformation. Their scalable approach meets a critical demand for effective addiction treatment. Offering great growth potential for investors.

2

Resilience

In a sector unaffected by economic downturns, Ethema’s mission thrives even during challenging times. This resilience proves that hope knows no recession. 

3

Development

Ethema combines world-class treatment with innovative techniques to set new standards in care. Investors can support a company dedicated to continuous development and improvement in addiction treatment.

Embrace the chance to be more than an investor; be a catalyst for change with Ethema Health Corporation. By investing with us, you’re not just securing a financial stake—you’re actively participating in a mission to transform lives affected by substance use disorders.
Ignite Change: Invest in Ethema Health Corporation
With a vision to heal and a strategy for growth, Ethema Health Corporation invites you to be part of something monumental. We’re opening the door to an investment opportunity designed for profound impact, offering nearly 4.2 billion shares at just $0.0012 each.

The minimum investment is just $500.

Invest Now

Shares Offered: 4,166,666,660 Reg-A

$0.0012 Per Share/$.12 Per Unit (100 Shares)

$5 Million Target Raise Amount

$500.00 Minimum Investment

The need is undeniable.
Effective treatment facilities are hard to find. Ethema is changing that.
14 Million Americans who battle serious alcohol dependency.
20 Million People who need substance abuse treatment in the U.S.
2.5 Million People in the U.S. who are addicted to opioids.
The Challenge We All Face

Across the United States, millions of lives are decimated by alcohol and drug addiction. This is far beyond a public health crisis; it’s a series of personal tragedies playing out in homes, workplaces, and communities every day.

Sadly, there are only 7,000 in-patient treatment centers that exist nationwide to treat the millions who suffer.

Ethema Health Corporation is poised to change this narrative, starting in the Southeast.

Learn More
Her Lifeline. Your Opportunity.

  • We are on a mission to expand our ability to heal by acquiring and merging similar treatment facilities.

  • This strategy allows us to serve more people in need, particularly in areas where such services are scarce.

  • We’ll boost the efficiency and quality of care by bringing together facilities under one operational model, ensuring we remain a steadfast resource, even in economic downturns.

  • Investing in Ethema means being part of a resilient and growing network of treatment centers dedicated to making a significant, lasting impact on individual and community health.

Join Us
Our Exciting Growth Trajectory
As past President of The American College of Emergency Physicians, our Chairman, Dr. Rosenberg has extensive connections with leading physician groups across the USA, allowing us to take a multi-faceted approach to growth. This includes direct marketing to hospitals and active participation in industry events.
Invest Now

More Reasons to Invest in Ethema Health Corporation

Stability
Backed by legislative support and insurance funding, we stand on a foundation of continuous support for our mission.
Team
Guided by leaders seasoned in making profound impacts, our team’s expertise is the cornerstone of our transformative vision.
Value
Transforming overlooked properties into beacons of hope and healing, our approach redefines the essence of value.
Acceleration
For strategic partnerships or acquisition, we offer a unique opportunity for forward-thinking investors to ignite change in a sector poised for growth.

FAQs

Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise – you are buying a piece of a company and helping it grow.
To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.
We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.
Individuals over 18 years of age can invest.
There will always be some risk involved when investing in a startup or small business. And the earlier you get in the more risk that is usually present. If a young company goes out of business, your ownership interest could lose all value. You may have limited voting power to direct the company due to dilution over time. You may also have to wait about five to seven years (if ever) for an exit via acquisition, IPO, etc. Because early-stage companies are still in the process of perfecting their products, services, and business model, nothing is guaranteed. That’s why startups should only be part of a more balanced, overall investment portfolio.
The Common Stock (the “Shares”) of Retrieve Medical (OTCMKTS: RMHI) (the “Company”) are publicly-traded. As a result, subject to satisfaction of applicable securities regulations (including applicable holding periods), holders of Shares may engage in public resales transactions.

Shares sold via Regulation Crowdfunding offerings have a one-year lockup period before those shares can be sold under certain conditions.

Exceptions to limitations on selling shares during the one-year lockup period:
In the event of death, divorce, or similar circumstance, shares can be transferred to:
• The company that issued the securities
• An accredited investor
• A family member (child, stepchild, grandchild, parent, stepparent, grandparent, spouse or equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships)

If a company does not reach their minimum funding target, all funds will be returned to the investors after the close of the offering.
All available disclosure information can be found on the offering pages for our Regulation Crowdfunding offering.
You can cancel your investment at any time, for any reason, until 48 hours prior to a closing occurring. If you’ve already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To submit a request to cancel your investment please email: ir@retrievemedical.com
At a minimum, the company will be filing with the SEC and posting on its website an annual report, along with certified financial statements. Those should be available 120 days after the fiscal year end. If the company meets a reporting exception, or eventually has to file more reported information to the SEC, the reporting described above may end. If these reports end, you may not continually have current financial information about the company.
Once an offering ends, the company may continue its relationship with DealMaker Securities for additional offerings in the future. DealMaker Securities’ affiliates may also provide ongoing services to the company. There is no guarantee any services will continue after the offering ends.
$1.50
The minimum investment size for this current round is $1,000.
Common
Approx $5 million
Investing in Retrieve Medical is an attractive opportunity for several reasons. First, they solve a compelling problem that improves patient outcomes, makes physicians’ lives easier, and improves hospital reimbursements. The demand is clear. The company’s recurring revenue model, based on a Software as a Service (SaaS) structure, ensures a steady and predictable income stream through regular billing. We know the tech works well because Retrieve Medical has already shown proven results in improving hospital reimbursements and operational efficiencies. And we know they can scale this solution because of their strategic relationships with major healthcare systems and vendors underscore a strong market presence and potential for further growth. The company is at the cutting edge of healthcare technology, employing AI and natural language processing, appealing to investors interested in innovative and future-focused businesses. Finally, as the healthcare sector continues to expand and evolve, especially with a focus on technology and efficiency, Retrieve Medical is well-positioned to benefit from these trends, offering investors a chance to be part of a company that’s not just profitable but also pivotal in enhancing healthcare operations and patient outcomes.
The model operates on a Software-as-a-service (SaaS) basis, meaning hospitals pay a recurring fee for using Retrieve Medical’s software. They charge hospitals $25 for each patient admitted, but this cost is offset by the significant increase in reimbursements hospitals receive due to improved documentation quality. Essentially, hospitals pay a small fee upfront but stand to gain much more in return. The return on investment (ROI) for hospitals using Retrieve Medical’s services is projected to be between 6X and 25X.
It’s a “no-brainer” for hospitals if it speeds up operations, makes physicians’ jobs easier, improves patient outcomes, and improves hospital reimbursement. They’ve already shown this technology can deliver those results.
They are just getting started so this is a true ground-floor opportunity.
Electronic documentation is already a big business (Epic does $4.6B in sales each year4). What makes this solution a new opportunity is it was built by the people who actually have to use electronic documentation systems, so they have firsthand experience of what the problems are and how to fix them in a way that works.
Working capital, additional software development, sales and marketing.
Bonus shares.
Investing in startups is risky and there is no guarantee you will get a return on your investment. However, an exit opens up the opportunity where you could convert your shares into cash or a more liquid asset. Exits include going public, getting acquired by a larger company, or our company buying back shares. If the value of our company grows, then you have a higher potential of making a profit on your investment during one of these exits.
If we are able to raise the full amount it is anticipated that this will allow us to get our product to market. We would expect to need additional capital at that time to market and sell the product.
Shares will be rewarded after the investment funds clear. This typically takes around 3 weeks after investment
No, costs are the same, regardless of how you invest.
No.

ETHEMA HEALTH is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Tier II of Regulation A. A copy of the Final Offering Circular that forms a part of the Offering Statement may be obtained from here.

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AVAILABLE HERE.

Access Form 1-A here

Forward Looking Statement Disclosure: This website contains forward-looking statements. These statements may include the words “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “project”, “will”, “may”, “targeting” and similar expressions as well as statements other than statements of historical facts including, without limitation, those regarding the financial position, business strategy, plans, targets and objectives of the management of Ethema Health Corporation (the “Company”) for future operations (including development plans and objectives). Such forward-looking statements involve known and unknown risks, uncertainties and other important factors which may affect the Company’s ability to implement and achieve the economic and monetary policies, budgetary plans, fiscal guidelines and other development benchmarks set out in such forward-looking statements and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company’s present and future policies and plans and the environment in which the Company will operate in the future. Furthermore, certain forward-looking statements are based on assumptions or future events which may not prove to be accurate, and no reliance whatsoever should be placed on any forward-looking statements in this presentation. The forward-looking statements in this website speak only as of the date of the Company’s  Form 1-A, and the Company expressly disclaims to the fullest extent permitted by law any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.